Vaccination

Rheumatology and COVID-19 at 1 year: facing the unknowns
Leonard Calabrese, Kevin L Winthrop

Annals of the Rheumatic Diseases Mar 2021, annrheumdis-2021-219957; DOI: 10.1136/annrheumdis-2021-219957
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
Martin Schäfer, Anja Strangfeld, Kimme L Hyrich, Loreto Carmona, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Laure Gossec, Philip C Robinson, Jinoos Yazdany, Pedro M Machado

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2021-220134; DOI: 10.1136/annrheumdis-2021-220134
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, Cristiano Alessandri, Fulvia Ceccarelli, Manuela Di Franco, Valeria Riccieri, Rossana Scrivo, Antonio Sili Scavalli, Francesca Romana Spinelli, Fabrizio Conti

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2021-220059; DOI: 10.1136/annrheumdis-2021-220059
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers
Pedro M Machado, Martin Schäfer, Anja Strangfeld, Laure Gossec, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Loreto Carmona, Kimme L Hyrich, Philip C Robinson, Jinoos Yazdany

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2021-220058; DOI: 10.1136/annrheumdis-2021-220058
EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs
Johannes WJ Bijlsma

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2020-219773; DOI: 10.1136/annrheumdis-2020-219773
Correspondence on ‘Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries’
Shamma Al Nokhatha, Neil MacEoin, Richard Conway

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2021-219847; DOI: 10.1136/annrheumdis-2021-219847
Response to: ‘Correspondence on ‘Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries’ by Nokhatha et al
Christian Dejaco, Johannes WJ Bijlsma, Frank Buttgereit

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2021-219866; DOI: 10.1136/annrheumdis-2021-219866
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey
Corrado Campochiaro, Giorgia Trignani, Alessandro Tomelleri, Stefano Cascinu, Lorenzo Dagna

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219811; DOI: 10.1136/annrheumdis-2020-219811
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1532-1543; DOI: 10.1136/annrheumdis-2020-217092
Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
Ruth E Costello, Jenny H Humphreys, Kevin L Winthrop, William G Dixon

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1665-1666; DOI: 10.1136/annrheumdis-2020-217255

Main menu

Vaccination

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Vaccination

Pages